ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H Cash Flow
HK:1541's free cash flow for Q4 2024 was ¥0.00. For the 2024 fiscal year, HK:1541's free cash flow was decreased by ¥231.81M and operating cash flow was ¥0.00. See a summary of the company’s cash flow.
Cash Flow
Dec 24
Dec 23
Dec 22
Dec 21
Operating Cash Flow
¥ -128.03M
¥ -367.55M
¥ -238.71M
¥ -190.54M
Investing Cash Flow
¥ 37.95M
¥ -294.85M
¥ 49.00K
¥ -108.72M
Financing Cash Flow
¥ 258.93M
¥ 331.04M
¥ 179.38M
¥ 793.03M
End Cash Position
¥ 477.60M
¥ 306.98M
¥ 635.21M
¥ 668.33M
Free Cash Flow
¥ -138.44M
¥ -370.25M
¥ -261.93M
¥ -315.79M
Currency in CNY
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H Cash Flow